"We succeeded in 'tricking' the virus by giving it part of the free ACE2 receptor [the synthetic peptide], which interacted ... with a low immune response to vaccines. The multidisciplinary ...

Compared with conventional vaccines, which are based on attenuated or inactivated microorganisms, synthetic peptides offer several advantages over other forms of vaccines, particularly with ...

EpiVacCorona is a single-dose synthetic peptide vaccine against COVID-19 developed by the Vector State Research Center of Virology and Biotechnology MOSCOW, June 11. /TASS/. Over three mln doses ...

Peptide-based vaccines deliver tumor-specific antigens to dendritic cells (DCs), triggering tumor-targeted T-cell responses. A peptide-peptide conjugate technology previously developed by researchers ...

The field of vaccinology is being transformed by peptide science, enabling more precise and personalized approaches to both preventive and therapeutic vaccines. Synthetic peptide antigens can be ...

Top-line data from the 42-patient study show that the synthetic peptide vaccine – which targets beta amyloid – was well-tolerated in subjects mild Alzheimer’s disease at the two doses ...

Patarroyo’s approach to creating a vaccine, for example, was particularly novel. He devised a mixture of three different synthetic peptides, each a ...

IO Biotech announced promising findings regarding a novel peptide vaccine designed to counter the immunosuppressive effects of Transforming Growth Factor Beta (TGF-β) in solid tumors. The ...

Those receiving ipilimumab, with or without the synthetic peptide vaccine glycoprotein 100 (gp100), had a median survival of about 10 months, against 6.4 months for the vaccine alone. Ipilimumab ...